The risk for readmission in schizophrenia patients treated with long-acting injectable (typical or atypical) versus oral antipsychotics

被引：0
作者：
Onn, R. [1 ]
Krivoy, A. [1 ,2 ]
Weizman, A. [1 ,2 ]
Hochman, E. [1 ,2 ]
Valevski, A. [1 ,2 ]
机构：
[1] Geha Mental Hlth Ctr, Psychiat, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30676-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.027
引用
收藏
页码：S494 / S494
页数：1
相关论文
共 50 条
[41]   Relapse with oral antipsychotics versus long-acting injectable antipsychotics: new paradoxical findings [J].
Jobe, Thomas H. ;
Harrow, Martin .
EVIDENCE-BASED MENTAL HEALTH, 2014, 17 (03) :84-84
[42]   Long-acting injectable antipsychotics for the treatment of schizophrenia in Spain [J].
Arango, Celso ;
Baeza, Inmaculada ;
Bernardo, Miquel ;
Canas, Fernando ;
de Dios, Consuelo ;
Diaz-Marsa, Marina ;
Paz Garcia-Portilla, Maria ;
Gutierrez-Rojas, Luis ;
Manuel Olivares, Jose ;
Rico-Villademoros, Fernando ;
Rodriguez-Jimenez, Roberto ;
Maria Sanchez-Morla, Eva ;
Segarra, Rafael ;
Crespo-Facorro, Benedicto .
REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2019, 12 (02) :92-105
[43]   LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN FIRST EPISODE SCHIZOPHRENIA [J].
Fleischhacker, Wolfgang .
SCHIZOPHRENIA BULLETIN, 2015, 41 :S312-S312
[44]   LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA: A 18 MONTHS STUDY [J].
Romero Guillena, S. L. ;
Gotor, F. ;
Plasencia Garcia de Diego, B. O. ;
Navarro Pablo, R. ;
Santamaria, O. .
EUROPEAN PSYCHIATRY, 2014, 29
[45]   Adherence and Long-Acting Injectable Antipsychotics in Schizophrenia: An Update [J].
Mohr, Pavel ;
Volavka, Jan .
DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2012, 25 (04) :285-296
[46]   The place of long-acting injectable antipsychotics in the treatment of schizophrenia [J].
Kane, John M. ;
Rubio, Jose M. .
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2023, 13
[47]   Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan [J].
Okada, Yusuke ;
Inada, Ken ;
Akazawa, Manabu .
SCHIZOPHRENIA RESEARCH, 2023, 252 :300-308
[48]   Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge [J].
Marcus, Steven C. ;
Zummo, Jacqueline ;
Pettit, Amy R. ;
Stoddard, Jeffrey ;
Doshi, Jalpa A. .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (09) :754-768
[49]   COST-EFFECTIVENESS OF INJECTABLE ATYPICAL LONG-ACTING ANTIPSYCHOTICS FOR CHRONIC SCHIZOPHRENIA IN POLAND [J].
Hemels, M. ;
Einarson, T. R. ;
Zilbershtein, R. ;
Schubert, A. ;
Skrzekowska-Baran, I ;
Van Impe, K. .
VALUE IN HEALTH, 2013, 16 (07) :A548-A548
[50]   Comparisons of the effects of long-acting injectable monotherapy and combination therapy of long-acting injectable treatment with oral antipsychotics on treatment retention in patients with chronic schizophrenia [J].
Suzuki, Hidenobu ;
Hibino, Hiroyuki ;
Inoue, Yuichi ;
Takaya, Atsuhiko .
ASIAN JOURNAL OF PSYCHIATRY, 2019, 39 :112-113
12345